Cisatracurium Besylate Injection
Product Images NDC 70069-151

9 FDA label images from Somerset Therapeutics, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 70069-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (8ebb3502 Ea0c 41a9 9878 F780cbe83383 01)

Image (8ebb3502 Ea0c 41a9 9878 F780cbe83383 01)
Chemical structure diagram of Cisatracurium Besylate, showing its molecular arrangement including aromatic rings, ester groups, and quaternary ammonium centers, with benzenesulfonate as the besylate component.*
FDA Label Image

Image (8ebb3502 Ea0c 41a9 9878 F780cbe83383 02)

Image (8ebb3502 Ea0c 41a9 9878 F780cbe83383 02)
A scatter plot chart showing percentage changes along two axes: HR (heart rate) on the vertical axis and MAP (mean arterial pressure) on the horizontal axis, both ranging from -60% to +60%. Data points are clustered near the center, indicating limited variation in HR and MAP values.*
FDA Label Image

Image (8ebb3502 Ea0c 41a9 9878 F780cbe83383 03)

Image (8ebb3502 Ea0c 41a9 9878 F780cbe83383 03)
A scatter plot chart showing data points comparing percentage changes in Mean Arterial Pressure (MAP) on the horizontal axis and Heart Rate (HR) on the vertical axis, each ranging from -60% to +60%. The chart appears to analyze cardiovascular parameter variability.*
FDA Label Image

2mg/ml (5ml) (Container Label)

2mg/ml (5ml) (Container Label)
Label for Cisatracurium Besylate Injection, USP 10 mg/5 mL (2 mg/mL) single-dose vial for intravenous use by Somerset Therapeutics, LLC. The label warns that this is a paralyzing agent requiring artificial respiration facilities and includes storage instructions to keep refrigerated between 2° to 8°C (36° to 46°F), with discard information. The product is made in India.*
FDA Label Image

2mg/ml (5ml) (Carton Label)

2mg/ml (5ml) (Carton Label)
Packaging label for Cisatracurium Besylate Injection, USP, 10 mg/5 mL (2 mg/mL) intravenous injection. The label includes warnings about its paralyzing effects and the need for facilities to be available for artificial respiration. It is manufactured for Somerset Therapeutics LLC. The label features black, red, and yellow text with barcodes and the Somerset Therapeutics logo.*
FDA Label Image

2mg/ml (5ml) (Innercarton 10s Pack)

2mg/ml  (5ml) (Innercarton 10s Pack)
Label for Cisatracurium Besylate Injection, USP 10 mg/5 mL (2 mg/mL) intravenous injection by Somerset Therapeutics, LLC. The label includes a warning about paralyzing agent risk and respiratory arrest, dosage information, storage instructions, and indicates the package contains 10 single-dose 5 mL vials. The product is manufactured in India and includes barcodes and contact details for Somerset Therapeutics.*
FDA Label Image

10mg/ml (20ml) (container label)

10mg/ml (20ml) (container label)
Label for Cisatracurium Besylate Injection, USP 10 mg/mL (200 mg/20 mL) single-dose vial, manufactured by Somerset Therapeutics, LLC. The label highlights a warning of paralysis and respiratory arrest, storage instructions at 2° to 8°C, and discard of unused portions. Made in India with barcode included.*
FDA Label Image

10mg/ml (20 mL) Carton Label (8ebb3502 Ea0c 41a9 9878 F780cbe83383 08)

10mg/ml (20 mL) Carton Label (8ebb3502 Ea0c 41a9 9878 F780cbe83383 08)
Carton label for Cisatracurium Besylate Injection, USP 10 mg/mL (200 mg/20 mL) by Somerset Therapeutics LLC. The label includes warnings about paralysis and respiratory arrest, storage instructions, and identifies the vial as single-dose with discard instructions. The label has barcode, NDC 70069-151-01, and the product is for intravenous use and ICU only.*
FDA Label Image

10 mg/ml (20 mL) Inner Carton (pack of 10s)

10 mg/ml (20 mL) Inner Carton (pack of 10s)
Packaging label for Cisatracurium Besylate Injection, USP, 10 mg/mL strength in a 200 mg/20 mL (10 mg/mL) intravenous injection. The label features a warning indicating it is a paralyzing agent and intended for ICU use only. It is manufactured by Somerset Therapeutics, LLC, Somerset, NJ. The package contains 10 single-dose vials of 20 mL each.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.